Blood Clotting Drug Recalled

AvKare Inc is voluntarily recalling 10 cartons of phytonadione tablets for failing to meet impurity specifications, according to the June 23, 2021, US Food and Drug Administration (FDA) Enforcement Report.

The recall affects phytonadione tablets, 5 mg, 30 tablets (10 tablets per card, 3 cards per carton; NDC 50268-661-13) from lot 38617 (Exp. 10/22). The tablets were manufactured for AvKare and distributed in Los Angeles, California.

AvKare initiated the recall June 9, 2021. On June 16, 2021, the FDA designated the recall Class III, suggesting use of the recalled tablets is not likely to cause harm.

Phytonadione is a prescription vitamin used to prevent bleeding in people with blood clotting problems or vitamin K deficiency.